Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
Primary Sjögren's syndrome related optic neuritis.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
Functionally Relevant White Matter Degradation in Multiple Sclerosis: A Tract-based Spatial Meta-Analysis.
Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
Hyaluronan Anchored to Activated CD44 on CNS Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis.
Differential Sox10 genomic occupancy in myelinating glia.
[Interferons and autoimmune diseases].
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Erythropoietin: new directions for the nervous system.
The Norwegian Multiple Sclerosis Registry and Biobank.
2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
Validation of the Social Provisions Scale in People With Multiple Sclerosis.
Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach.

Pages